Here are five things to know:
1. Mr. Lucier purchased 34,000 shares.
2. The shares were purchased at $49.25 on average.
3. The total transaction value was $1.6 million.
4. There are 1.54 percent of the shares held by the company insiders and 99 percent are held by institutions.
5. NuVasive’s market cap is $2.3 billion.
Mr. Lucier assumed the company’s top position after the former CEO stepped down due to compliance issues.
More articles on orthopedic devices:
LESS Institute gets $30M senior credit facility—5 key notes
8 key trends in the global 3D printing medical applications market
Medtronic sets its sights on China—5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
